{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:37:07Z","timestamp":1788255427530,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T00:00:00Z","timestamp":1386201600000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.virol.2012.07.020","type":"journal-article","created":{"date-parts":[[2012,8,11]],"date-time":"2012-08-11T05:16:33Z","timestamp":1344662193000},"page":"18-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence"],"prefix":"10.1016","volume":"434","author":[{"given":"Amy B.","family":"Papaneri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wirblich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Cann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Jahrling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Blaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2012.07.020_bib1","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1126\/science.1133105","article-title":"Ebola outbreak killed 5000 gorillas","volume":"314","author":"Bermejo","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.virol.2012.07.020_bib2","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.1128\/JVI.00558-11","article-title":"Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses","volume":"85","author":"Blaney","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.07.020_bib3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4161\/hv.7.6.15398","article-title":"Filovirus vaccines","volume":"7","author":"Bradfute","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.virol.2012.07.020_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.virol.2010.01.015","article-title":"Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic","volume":"399","author":"Bukreyev","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.07.020_bib5","first-page":"304","article-title":"Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries","volume":"80","author":"Cleaveland","year":"2002","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.virol.2012.07.020_bib6","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies","volume":"86","author":"Faber","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2012.07.020_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.vaccine.2009.10.051","article-title":"Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge","volume":"28","author":"Faul","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.07.020_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/rmv.661","article-title":"Prospects for immunisation against Marburg and Ebola viruses","volume":"20","author":"Geisbert","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2012.07.020_bib9","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1128\/JVI.01870-09","article-title":"Characterization of a single-cycle rabies virus-based vaccine vector","volume":"84","author":"Gomme","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.07.020_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-387040-7.00009-3","article-title":"Rabies virus as a research tool and viral vaccine vector","author":"Gomme","year":"2011","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2012.07.020_bib11","doi-asserted-by":"crossref","first-page":"e1000904","DOI":"10.1371\/journal.ppat.1000904","article-title":"Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species","volume":"6","author":"Hensley","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2012.07.020_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7589\/0090-3558-38.2.352","article-title":"Development of a bait and baiting system for delivery of oral rabies vaccine to free-ranging African wild dogs (Lycaon pictus)","volume":"38","author":"Knobel","year":"2002","journal-title":"J. Wildl. Dis."},{"key":"10.1016\/j.virol.2012.07.020_bib13","doi-asserted-by":"crossref","first-page":"e8375","DOI":"10.1371\/journal.pone.0008375","article-title":"How Ebola impacts genetics of Western lowland gorilla populations","volume":"4","author":"Le Gouar","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2012.07.020_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1092528","article-title":"Multiple Ebola virus transmission events and rapid decline of central African wildlife","volume":"303","author":"Leroy","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.virol.2012.07.020_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1473-3099(04)01103-X","article-title":"Pathogenesis of filoviral haemorrhagic fevers","volume":"4","author":"Mahanty","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2012.07.020_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"McGettigan","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.07.020_bib17","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1073\/pnas.93.14.7310","article-title":"Highly stable expression of a foreign gene from rabies virus vectors","volume":"93","author":"Mebatsion","year":"1996","journal-title":"Proc. Natl. Acad. Sci., USA"},{"key":"10.1016\/j.virol.2012.07.020_bib18","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1016\/j.vaccine.2011.04.045","article-title":"Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge","volume":"29","author":"Mustafa","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.07.020_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3201\/eid1102.040533","article-title":"Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003","volume":"11","author":"Rouquet","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2012.07.020_bib20","series-title":"Fields virology","first-page":"1409","article-title":"Filoviridae: Marburg and Ebola viruses","author":"Sanchez","year":"2007"},{"key":"10.1016\/j.virol.2012.07.020_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2012.07.020_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/viro.2001.1212","article-title":"Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines","volume":"292","author":"Siler","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.07.020_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2008.09.020","article-title":"Protection against lethal challenge by Ebola virus-like particles produced in insect cells","volume":"383","author":"Sun","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.07.020_bib24","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1126\/science.314.5805.1522","article-title":"Ecology Tracking Ebola's deadly march among wild apes.","volume":"314","author":"Vogel","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.virol.2012.07.020_bib25","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.317.5844.1484","article-title":"Conservation. Scientists say Ebola has pushed western gorillas to the brink","volume":"317","author":"Vogel","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.virol.2012.07.020_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0950268899002666","article-title":"An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species","volume":"123","author":"Vos","year":"1999","journal-title":"Epidemio. Infect."},{"key":"10.1016\/j.virol.2012.07.020_bib27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7589\/0090-3558-38.2.428","article-title":"Safety studies of the oral rabies vaccine SAD B19 in striped skunk (Mephitis mephitis)","volume":"38","author":"Vos","year":"2002","journal-title":"J. Wildl. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.virol.2012.07.020_bib28","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"Warfield","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.07.020_bib29","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.1128\/JVI.01309-10","article-title":"Rabies virus glycoprotein expression levels are not critical for pathogenicity of RV","volume":"85","author":"Wirblich","year":"2011","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212003698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212003698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:17:09Z","timestamp":1758586629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682212003698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0042682212003698"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2012.07.020","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2012.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}